Clinical Trials Logo

Clinical Trial Summary

This Study is to evaluate the safety and pharmacokinetics of a fixed dose combination formulation and co-administration.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05085184
Study type Interventional
Source Korea United Pharm. Inc.
Contact
Status Active, not recruiting
Phase Phase 1
Start date September 6, 2021
Completion date September 5, 2022